Table 1.
Group 1 | Group 2 | |
---|---|---|
Patients | 11 | 18 |
Gender (M/F) | 4/7 | 6/12 |
Mean age (range) | 60 (38–69) | 61 (37–87) |
Primary tumour | ||
Kidney | 3 | 6 |
Melanoma | 2 | 0 |
Prostate | 1 | 0 |
Breast | 1 | 4 |
Thyroid | 2 | 1 |
Lung | 1 | 0 |
Colon | 1 | 3 |
Metastatic sarcoma | 0 | 1 |
Bladder | 0 | 1 |
Endometrioid carcinoma | 0 | 1 |
Site of involvement | ||
Femur | 6 | 2 |
Pelvis | 2 | 7 |
Scapula | 1 | 0 |
Tibia | 1 | 4 |
Sacrum | 0 | 3 |
Humerus | 1 | 1 |
Previous local treatment | ||
Radiotherapy | 6 | 11 |
Embolization | 1 | 2 |
HiFu | 0 | 1 |